Search Browse Earnings

BIODESIX INC — SlamSEC

BIODESIX INC

Nasdaq:BDSX

Services-Medical Laboratories·LOUISVILLE, CO

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$71.3M

+45.3% YoY

FY 2025

Adj. EBITDA

-$28.7M

-40.3% margin

FY 2025

Net Income

-$42.9M

-60.2% margin

FY 2025

EPS (Diluted)

-$6.64

FY 2025

Stock Price

$19.27

+2.6%

2026-03-09

52W Range

$3.44 – $19.71

P/E Ratio

-2.9x

Market Cap

$190.0M

Cash

$26.2M

FY 2025

Total Debt

$50.0M

FY 2025

Net Debt

$23.8M

FY 2025

Enterprise Value

$213.8M

Debt / EBITDA

-0.8x

FY 2025

EV / EBITDA

-7.4x

Employees

—